脑部放疗，上午比下午敏感许多！% h9 ~5 y# J# T% u+ b' |
3 \7 w1 ^/ `- j3 Y+ J: z6 E* Q
]8 B9 p0 p9 Q/ W. oCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
5 [) c; B+ v, A6 `1 }9 n! ?# N8 O+ z* ` IGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
' ]9 g% `5 X8 ~$ n9 N9 q, q: hRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
Q+ d5 y7 n2 I; dSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.* m+ ~; w J8 f2 s
# a* |9 f0 h: E9 ^( R
Abstract
9 `; Y) @6 z" s7 m: U' K8 rBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
) ^ u( |* |9 h6 ^% }: D* U5 I- M" Z$ t
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
0 Z6 T8 p9 u9 _, y: Q5 o: o8 P$ Y3 K* S$ |7 |
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).' i( D$ a# F6 ?5 U
' R: S5 J6 H3 h) i
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.# [! e3 s+ @6 ^) x" O
4 d+ p# h0 ~0 C( d* r% w
|
显身卡
